This paper investigates the industrialization of biomedical materials at the New England Enzyme Center (NEEC) from its establishment as a federally supported biochemical resource center in 1964 through its demise and refashioning into several commercial biotech companies in the late 1970s. It sets this history within the long-standing debate on the proper relation between science and American economic and political traditions. The NEEC sought to embody two aims that stood in tension: academic independence in knowledge production and the market-driven interests of the biomedical industry. A clash of values ensued, but built on a particular notion of independence: scientists pragmatically accepted the primacy of the market in the age of the 'federal research economy.' The question became how to carve out a space for science and scientific values in the market - an intellectual position that some legal and economic scholars have referred to as a scientific commons. Even so, industry executives came to see the idea of a scientific commons and public knowledge as obstructive to industrial innovation. This paper argues that, as seen through the case of the NEEC, the ascendancy of market values and attitudes in the 1970s played a critical role in reconfiguring the science-industry relationship and in 'industrializing' the life sciences. As illustration of this change, I look at a commercial firm - Genzyme - born out of NEEC's dissolution. [ABSTRACT FROM AUTHOR]
...More
Book
Hughes, Sally Smith;
(2011)
Genentech: The Beginnings of Biotech
Article
Smart, Andrew;
Martin, Paul;
(2006)
The Promise of Pharmacogenetics: Assessing the Prospects for Disease and Patient Stratification
Article
Hughes, Sally Smith;
(2001)
Making Dollars out of DNA: The First Major Patent in Biotechnology and the Commercialization of Molecular Biology, 1974--1980
Article
Prebble, John N.;
(2013)
Contrasting Approaches to a Biological Problem: Paul Boyer, Peter Mitchell and the Mechanism of the ATP Synthase, 1961--1985
Thesis
Moxley, Shera A.;
(2012)
Designer Drugs: Rational Therapeutics in the Biotechnology Era, 1973--1997
Thesis
Jones, Mark Peter;
(2005)
Biotech's Perfect Climate: The Hybritech Story
Thesis
Gozubuyuk, Remzi;
(2007)
The Position of the Firm in Scientific and Alliance Networks: Social Structural Determinants of Innovation in the United States Biotechnology Industry, 1990--2002
Thesis
Frank, Jeffrey Evan;
(2001)
The Biotechnology Industry in the United States: Formulating a Conceptual Industry Model
Book
Brady, Catherine;
(2007)
Elizabeth Blackburn and the Story of Telomeres: Deciphering the Ends of DNA
Article
Santesmases, María Jesús;
(2002)
Enzymology at the Core: Primers and Templates in Severo Ochoa's Transition from Biochemistry to Molecular Biology
Book
Rabinow, Paul;
Dan-Cohen, Talia;
(2005)
A Machine to Make a Future: Biotech Chronicles
Article
Welsh, Rick;
Glenna, Leland;
(2006)
Considering the Role of the University in Conducting Research on Agri-biotechnologies
Article
Jones, Mark Peter;
(2009)
Entrepreneurial Science: The Rules of the Game
Article
Jong, Simcha;
(2006)
How Organizational Structures in Science Shape Spin-off Firms: The Biochemistry Departments of Berkeley, Stanford, and UCSF and the Birth of the Biotech Industry
Article
Bud, Robert;
(2010)
From Applied Microbiology to Biotechnology: Science, Medicine and Industrial Renewal
Book
Vettel, Eric James;
(2006)
Biotech: The Countercultural Origins of an Industry
Article
Santesmases, María Jesús;
(2006)
Peace Propaganda and Biomedical Experimentation: Influential Uses of Radioisotopes in Endocrinology and Molecular Genetics in Spain
Article
Waldby, Catherine;
(2009)
Singapore Biopolis: Bare Life in the City-State
Article
Loison, Laurent;
(2013)
Monod before Monod: Enzymatic Adaptation, Lwoff, and the Legacy of General Biology
Article
Helvoort, Ton van;
(2002)
Institutionalizing Biochemistry: The Enzyme Institute at the University of Wisconsin
Be the first to comment!